
    
      This is an observational prospective study to better understand the clinical impact of
      Pulmonary Arterial Hypertension (PAH) specific therapy in patients with atypical PAH among
      those with risk factors for left heart disease

      The study involves detailed baseline clinical evaluation prior to initiation of PAH therapy,
      followed by repeat clinical assessment after 6 months of medical therapy
    
  